Two Sigma Investments »

Adaptimmune Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2025-03-31 $27k 136k 0.20
2024-12-31 $41k 76k 0.54
2024-09-30 $54k 57k 0.95
2024-03-31 $23k 15k 1.58
2023-09-30 $47k 60k 0.78
2023-06-30 $102k 110k 0.93
2023-03-31 $17k 15k 1.09
2022-12-31 $33k 23k 1.46
2022-03-31 $544k 264k 2.06